Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
This study has been completed.
Study NCT00502736   Information provided by Hoffmann-La Roche
First Received: July 17, 2007   Last Updated: September 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Bone Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Bone Diseases
Breast Diseases
Musculoskeletal Diseases
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Skin Diseases
Interventions listed in this trial
ibandronate [Bondronat]
Additional drug interventions recognized in this trial
Ibandronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Hoffmann-La Roche


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services